Targeted Medical Pharma, Inc. (TRGM)

Market Cap	206.00 +610.3%
Revenue (ttm)	5.26M -26.0%
Net Income	-3.04M
EPS	-0.11
Shares Out	29.47M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,900
Open	0.000007
Previous Close	0.000001
Day's Range	0.000007 - 0.000007
52-Week Range	0.000001 - 0.0246
Beta	-49.58
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Targeted Medical Pharma

Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyal...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 30
• Stock Exchange: OTCMKTS
• Ticker Symbol: TRGM

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 25, 2026

Data Sources Report a data error